BIOMAT Database Logo BIOMAT Database Logo

Characterization of a carboxy-terminal BRCA1 interacting protein. 1998

A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Myriad Genetics, Inc., Salt Lake City, Utah 84108, USA.

There are several lines of evidence indicating that the carboxy-terminal region of the tumor suppressor protein BRCA1 is a functionally significant domain. Using the yeast two-hybrid and in vitro biochemical assays, we show that a protein, CtIP, interacts specifically with the carboxy-terminal segment of human BRCA1 from residues 1602-1863. A germ line truncation mutation, Y1853ter, that removes the last 11 amino acids from the carboxy-terminus of BRCA1, abolishes not only its transcriptional activation function, but also binding to CtIP. The function of CtIP is unknown, but its reported association with a transcriptional repressor CtBP lends further support that it may have a role in transcription. A sequence based screen of a panel of 89 tumor cell line cDNAs for mutations in the CtIP coding region identified five missense variants. In the pancreatic carcinoma cell line, BxPC3, the non-conservative lysine to glutamic acid change at codon 337 is accompanied with apparent loss of heterozygosity or non-expression of the wild type allele. Thus it is plausible that CtIP may itself be a tumor suppressor acting in the same pathway as BRCA1.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D017930 Genes, Reporter Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest. Reporter Genes,Gene, Reporter,Reporter Gene
D018095 Germ-Line Mutation Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not. Mutation, Germ-Line,Germline Mutation,Germ Line Mutation,Germ-Line Mutations,Germline Mutations,Mutation, Germ Line,Mutation, Germline,Mutations, Germ-Line,Mutations, Germline

Related Publications

A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
[Isolation and characterization of a BRCA1-interacting protein].
December 2003, Yi chuan xue bao = Acta genetica Sinica,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.
August 2004, Molecular and cellular biology,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Polyadenylation site selection: linking transcription and RNA processing via a conserved carboxy-terminal domain (CTD)-interacting protein.
May 2017, Current genetics,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Carboxy-terminal determinants of intracellular protein degradation.
February 1990, Genes & development,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Identifying the carboxy terminal amino acid of a protein.
January 1997, Methods in molecular biology (Clifton, N.J.),
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motif.
June 2004, The Journal of biological chemistry,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Selective isolation of the carboxy terminal peptide from a protein.
January 1997, Methods in molecular biology (Clifton, N.J.),
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
January 2014, PloS one,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovarian borderline tumor organoids.
January 2023, Biochemical and biophysical research communications,
A K Wong, and P A Ormonde, and R Pero, and Y Chen, and L Lian, and G Salada, and S Berry, and Q Lawrence, and P Dayananth, and P Ha, and S V Tavtigian, and D H Teng, and P L Bartel
Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
March 2023, World journal of surgical oncology,
Copied contents to your clipboard!